Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 63Colonic Neoplasms 29Rectal Neoplasms 25Neoplasm Metastasis 11Stomach Neoplasms 8Carcinoma, Hepatocellular 7Pancreatic Neoplasms 6Neoplasms 6Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Liver Neoplasms 3Ovarian Neoplasms 2Esophageal Squamous Cell Carcinoma 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Peritoneal Neoplasms 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Melanoma 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gastrointestinal Neoplasms 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Lidocaine 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cold Hypersensitivity × Folfox protocol × Clear all
NCT03254394 2022-03-09

Lidocaine for Oxaliplatin-induced Neuropathy

Washington University School of Medicine

Phase 1/2 Completed
26 enrolled 10 charts
Gastrointestinal

Neuropathy, Painful, Cold Hypersensitivity, Neuralgia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡